US Supreme Court Docket

Supreme Court Docket

Oct | Nov | Dec | Jan | Feb | Mar | Apr | Unscheduled | Previous Terms
[Download October 2, 2006 Argument Calendar PDF]
[Download October 30, 2006 Argument Calendar PDF]
[Click here for 2005 Docket]
Many documents listed on this page are PDF files that may be viewed using AdobeReader.

MedImmune, Inc. v. Genentech, Inc.
No. 05-608 Title:

MedImmune, Inc. v. Genentech, Inc.

Subject:

Justiciability, Patents, Intellectual Property, Declaratory Judgment Act

Question:

Does Article III's grant of jurisdiction of "all Cases . . . arising under . . . the Laws of the United States," implemented in the "actual controversy" requirement of the Declaratory Judgment Act, 28 U.S.C. section 2201(a), require a patent licensee to refuse to pay royalties and commit material breach of the license agreement before suing to declare the patent invalid, unenforceable or not infringed?

Decisions:

• U.S. Court of Appeals - Federal Circuit Opinion Filed: October 18, 2005
• United States Supreme Court, Cert. Granted: February 21, 2006
• United States Supreme Court, Decided: January 9, 2007

Resources:

• Docket Sheet From the U.S. Supreme Court.
• Northwestern University - Medill School of Journalism: On the Docket

Briefs:

    Parties

Petition Phase

• Certiorari Petition
• Opposition to Petition
• Reply to Opposition
  
  Merits Phase
  
• Petitioner MedImmune
• Respondent Genentech
• Respondent City of Hope
  
  Amici Supporting Petitioner
• Amicus NRDC
• Amicus Solicitor General
• Amici Law Professors
• Amicus Generic Pharm. Ass'n
• Amicus Medtronic
  
  Amici Supporting Neither Party
  
• Amicus Licensing Executives Society
  
  Amici Supporting Respondent
  
• Amicus Pharm. Research & Manuf. of Am.
• Amici Licensing Experts
• Amici Law Professors
• Amici Law Professors
• Amici Qualcomm et al.
• Amici Universities
• Amicus AIPLA
• Amici 3M, et al.
• Amicus BPLA
• Amicus NYIPLA

Counsel of Record

For Petitioner MedImmune, Inc.:

Harvey Kurzweil
Dewey Ballantine, LLP
New York, NY

For Respondent Genentech, Inc.:

Daniel M. Wall
Latham & Watkins LLP
San Francisco, CA

 

Oct | Nov | Dec | Jan | Feb | Mar | Apr | Unscheduled | Previous Terms

 

To view PDF files listed on this page you will need Adobe Acrobat Reader